当前位置:首页 - 行情中心 - 康辰药业(603590) - 财务分析 - 现金流量表

康辰药业

(603590)

  

流通市值:84.73亿  总市值:85.77亿
流通股本:1.57亿   总股本:1.59亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金395,655,319.72174,532,864.04863,943,830.85642,806,947.31
  收到的税费返还--16,585,029.21-
  收到其他与经营活动有关的现金11,447,932.941,170,403.0235,307,501.3431,875,356.11
  经营活动现金流入小计407,103,252.66175,703,267.06915,836,361.4674,682,303.42
  购买商品、接受劳务支付的现金31,440,009.1219,442,164.467,324,089.658,097,393.7
  支付给职工以及为职工支付的现金153,431,689.2885,383,454.82226,090,521.73163,263,397.95
  支付的各项税费31,957,530.686,648,626.6228,119,661.9519,206,292.63
  支付其他与经营活动有关的现金201,951,157.395,741,228.55422,056,909.63322,398,116.93
  经营活动现金流出小计418,780,386.38207,215,474.39743,591,182.91562,965,201.21
  经营活动产生的现金流量净额-11,677,133.72-31,512,207.33172,245,178.49111,717,102.21
二、投资活动产生的现金流量:
  收回投资收到的现金820,000,000170,000,0001,280,762,198.32950,762,198.32
  取得投资收益收到的现金11,419,895.411,164,986.2919,827,717.1513,349,890.5
  处置固定资产、无形资产和其他长期资产收回的现金净额155,000-30,39527,580
  投资活动现金流入小计831,574,895.41171,164,986.291,300,620,310.47964,139,668.82
  购建固定资产、无形资产和其他长期资产支付的现金27,583,874.1422,522,406.22104,020,597.1866,664,252.99
  投资支付的现金560,000,000110,000,0001,395,000,000930,000,000
  投资活动现金流出小计587,583,874.14132,522,406.221,499,020,597.18996,664,252.99
  投资活动产生的现金流量净额243,991,021.2738,642,580.07-198,400,286.71-32,524,584.17
三、筹资活动产生的现金流量:
  取得借款收到的现金84,705,761.6239,659,140217,549,110.14160,714,410.89
  收到其他与筹资活动有关的现金--9,683,504.89,683,504.8
  筹资活动现金流入小计84,705,761.6239,659,140227,232,614.94170,397,915.69
  偿还债务支付的现金35,995,679.1421,153,982.14171,513,337.58108,528,700.58
  分配股利、利润或偿付利息支付的现金98,533,179.921,436,169.3553,492,097.0451,876,876.42
  支付其他与筹资活动有关的现金6,161,508.312,046,661.8110,498,487.726,116,772.1
  筹资活动现金流出小计140,690,367.3724,636,813.3235,503,922.34166,522,349.1
  筹资活动产生的现金流量净额-55,984,605.7515,022,326.7-8,271,307.43,875,566.59
四、汇率变动对现金及现金等价物的影响7,729.741,218.83-2,816,383.01-2,528,969.64
五、现金及现金等价物净增加额176,337,011.5422,153,918.27-37,242,798.6380,539,114.99
  加:期初现金及现金等价物余额189,977,701.84189,977,701.84227,220,500.47227,220,500.47
  期末现金及现金等价物余额366,314,713.38212,131,620.11189,977,701.84307,759,615.46
补充资料:
  净利润96,334,639.19-21,530,544.55-
  资产减值准备--105,547,311.98-
  固定资产和投资性房地产折旧10,238,902.29-21,731,837.09-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧10,238,902.29-21,731,837.09-
  无形资产摊销5,104,167.39-9,506,245.02-
  长期待摊费用摊销104,582.85-525,652.42-
  处置固定资产、无形资产和其他长期资产的损失-130,668.15-7,331.58-
  固定资产报废损失--25,320.95-
  公允价值变动损失-379,689.56-486,686.56-
  财务费用3,317,561.87-8,971,882.16-
  投资损失-10,015,947.42--18,142,328.06-
  递延所得税5,425,652.75-6,457,429.54-
  其中:递延所得税资产减少5,658,086.96-4,806,844.47-
    递延所得税负债增加-232,434.21-1,650,585.07-
  存货的减少2,862,145.22--24,051,503.5-
  经营性应收项目的减少-89,917,750.62-32,671,622.51-
  经营性应付项目的增加-52,540,620.67--26,552,281.64-
  其他4,099,873.13-21,884,494.7-
  现金的期末余额366,314,713.38-189,977,701.84-
  减:现金的期初余额189,977,701.84-227,220,500.47-
  现金及现金等价物的净增加额176,337,011.54--37,242,798.63-
公告日期2025-08-282025-04-262025-04-262024-10-30
审计意见(境内)标准无保留意见
TOP↑